chr4-82917014-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024672.6(THAP9):āc.802G>Cā(p.Glu268Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000019 in 1,582,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024672.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
THAP9 | NM_024672.6 | c.802G>C | p.Glu268Gln | missense_variant | 5/5 | ENST00000302236.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
THAP9 | ENST00000302236.10 | c.802G>C | p.Glu268Gln | missense_variant | 5/5 | 1 | NM_024672.6 | P1 | |
THAP9 | ENST00000505901.1 | c.*559G>C | 3_prime_UTR_variant, NMD_transcript_variant | 6/6 | 2 | ||||
THAP9 | ENST00000506208.1 | c.*173G>C | 3_prime_UTR_variant, NMD_transcript_variant | 4/4 | 3 | ||||
LIN54 | ENST00000505905.1 | n.305-3573C>G | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000443 AC: 1AN: 225834Hom.: 0 AF XY: 0.00000817 AC XY: 1AN XY: 122388
GnomAD4 exome AF: 6.99e-7 AC: 1AN: 1430794Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 710096
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.802G>C (p.E268Q) alteration is located in exon 5 (coding exon 5) of the THAP9 gene. This alteration results from a G to C substitution at nucleotide position 802, causing the glutamic acid (E) at amino acid position 268 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at